WPI 3248 (Valacyclovir 500 mg)

Pill imprint WPI 3248 has been identified as Valacyclovir hydrochloride 500 mg.

Valacyclovir is used in the treatment of herpes simplex, suppression; cold sores; herpes simplex, mucocutaneous/immunocompetent host; cytomegalovirus infection; ramsay hunt syndrome (and more), and belongs to the drug class purine nucleosides. There is no proven risk in humans during pregnancy. Valacyclovir 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WPI 3248

Valacyclovir hydrochloride 500 mg WPI 3248
Valacyclovir hydrochloride 500 mg WPI 3248
Valacyclovir hydrochloride 500 mg WPI 3248
Valacyclovir hydrochloride
Imprint:
WPI
3248
Strength:
500 mg
Color:
Blue
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Purine nucleosides
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-3248
Inactive Ingredients:
croscarmellose sodium
FD&C Blue No. 2
hydrogenated castor oil
hypromelloses
polyethylene glycol
polysorbate 80
corn starch
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)